These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8729907)
61. Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells. Wiechen K; Karaaslan S; Turzynski A; Dietel M Br J Cancer; 1999 Nov; 81(5):790-5. PubMed ID: 10555747 [TBL] [Abstract][Full Text] [Related]
62. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast. Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302 [TBL] [Abstract][Full Text] [Related]
63. Targeted tumor killing via an intracellular antibody against erbB-2. Deshane J; Siegal GP; Alvarez RD; Wang MH; Feng M; Cabrera G; Liu T; Kay M; Curiel DT J Clin Invest; 1995 Dec; 96(6):2980-9. PubMed ID: 8675670 [TBL] [Abstract][Full Text] [Related]
64. Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Deshane J; Cabrera G; Grim JE; Siegal GP; Pike J; Alvarez RD; Curiel DT Gynecol Oncol; 1995 Oct; 59(1):8-14. PubMed ID: 7557620 [TBL] [Abstract][Full Text] [Related]
65. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2. Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517 [TBL] [Abstract][Full Text] [Related]
66. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines. Deshane J; Loechel F; Conry RM; Siegal GP; King CR; Curiel DT Gene Ther; 1994 Sep; 1(5):332-7. PubMed ID: 7584099 [TBL] [Abstract][Full Text] [Related]